Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Research Use Disclaimer The compounds distributed by USA PEPTIDE SCIENCES , including Cagrilintide 10mg research vials, are designated strictly for laboratory research purposes only
Retarutide inhibited human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775nM, respectively
Parameters for repair Dis Colon Rectum 33 891901 Occurrence Handle2209281 Occurrence Handle10.1007/BF02051930 Occurrence Handle1:STN:280:By6D3crmtlw%3D K Ishimura T Tsubouchi K Okano T Maeba H Maeta (1998) ArticleTitleWound healing of intestinal anastomosis after digestive surgery under septic condition: participation of local interleukin-6 expression World J Surg 22 106975 Occurrence Handle9747169 Occurrence Handle10.1007/s002689900519 Occurrence Handle1:STN:280:DyaK1cvhvFejtA%3D%3D M Veljaca CA Lesch B Sanchez J Low A Guglietta (1995) ArticleTitleProtection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action Gastroenterology 108 936 S Frank M Madlener J Pfeilschifter S Werner (1998) ArticleTitleInduction of inducible nitric oxide synthase and its corresponding retrahydrobiopterin-cofactor synthesizing enzyme GTP-cyclohydrolase I during cutaneous wound repair J Invest Dermatol 111 105864 Occurrence Handle9856817 Occurrence Handle10.1046/j.1523-1747.1998.00434.x Occurrence Handle1:CAS:528:DyaK1cXnvFyit7o%3D JA Attard MJ Raval GR Martin J Kolb M Afrouzian WD Buie et al
The Connectivity Map (CMap) analysis by Iorio et al
Waist circumference reductions were also dose-dependent for Cagrilintide, notably at 1.24.5 mg, exceeding those in the placebo group and approximating the reductions seen with liraglutide 3.0 mg
